Quinn A D, O'Hare N J, Wallis F J, Wilson G F
Diagnostic Imaging Department, St. James's Hospital, Dublin, Ireland.
J Comput Assist Tomogr. 1994 Jul-Aug;18(4):634-6.
The purpose of this study was to demonstrate that gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) could be used as a contrast medium in CT as an alternative to iodine-based compounds.
Solutions of different concentrations of Gd-DTPA and iopromide were scanned in a tissue equivalent phantom and it was shown that Gd-DTPA caused 2.5 times the attenuation of an equimolar solution of iopromide. From these in vitro studies an in vivo dose of 0.5 mmol/kg Gd-DTPA was calculated to be equivalent to 50 ml iopromide 300.
Pre- and postenhancement CT was performed in a volunteer using Gd-DTPA intravenously, and adequate enhancement occurred in intracranial vessels.
Gd-DTPA can be used to provide enhancement during CT and might be of value in iodine-sensitive patients.
